Associated Liver Partition and Portal Vein Ligation (ALPPS) vs selective Portal Vein Ligation (PVL) for staged hepatectomy in a rat model. Similar regenerative response?

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  García Pérez, Rocío ^a   Revilla Nuin, Beatriz ^a,b   Martínez, Carlos M ^a,b   Bernabé García, Angel ^a   Baroja Mazo, Alberto ^a   Parrilla Paricio, Pascual ^a,b  

^a Department of Surgery   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSOCIATED LIVER PARTITION AND PORTAL VEIN LIGATION; CONTROLLED STUDY; INTERMETHOD COMPARISON; LIVER ATROPHY; LIVER HYPERTROPHY; LIVER INJURY; LIVER REGENERATION; LIVER RESECTION; MALE; MORBIDITY; NONHUMAN; PORTAL VEIN LIGATION; PROTEIN EXPRESSION; RAT; SURGICAL MORTALITY; SURGICAL TECHNIQUE; VEIN LIGATION; ANIMAL; ARTIFICIAL EMBOLIZATION; CELL PROLIFERATION; HEPATIC PORTAL VEIN; HYPERTROPHY; LIGATION; LIVER; LIVER NEOPLASMS; METABOLISM; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; VASCULAR SURGERY;

ANIMALS; CELL PROLIFERATION; EMBOLIZATION, THERAPEUTIC; HEPATECTOMY; HYPERTROPHY; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIGATION; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; MALE; PORTAL VEIN; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR SURGICAL PROCEDURES;

EID: 84956599733     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144096     Document Type: Article

References (47)

1. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 2000; 6:777-85
2. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007; 356:1545-59. PMID: 17429086
3. Tanaka K, Shimada H, Matsuo K, Ueda M, Endo I, Togo S. Regeneration after two-stage hepatectomy vs. repeat resection for colorectal metastasis recurrence. J. Gastrointest Surg 2007; 11:1154-61. PMID: 17623261
4. Broering DC, Hillert C, Krupski G, Fischer L, Mueller L, Achilles EG, et al. Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 2002; 6:905-13. PMID: 12504230
5. Wilms C, Mueller L, Lenk C, Wittkugel O, Helmke K, Krupski-Berdien G, et al. Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg 2008; 247:825-34. doi: 10.1097/SLA.0b013e31816a9d7c PMID: 18438120
6. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous vein embolization. Ann Surg 2000; 231:480-6. PMID: 10749607
7. Kokudo N, Tada K, Seki M, Ohta H, Yamaguchi T, Matsubara T, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology. 2001; 34:267-72. PMID: 11481611
8. Heinrich S, Lang H. Liver metastases from colorectal cancer: technique of liver resection. J Surg Oncol 2013; 107:579-84. doi: 10.1002/jso.23138 PMID: 22566374
9. Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N, et al. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 2008; 12:297-303. PMID: 18060468
10. Furrer K, Tian Y, Pfammatter T, Jochum W, El-Badry AM, Graf R, et al. Selective portal vein embolization and ligation trigger different regenerative responses in the rat liver. Hepatology 2008; 47:1615-23. doi: 10.1002/hep.22164 PMID: 18395841
11. Tashiro S. Mechanism of liver regeneration after liver resection and portal vein embolization (ligation) is different?. Hepatobiliary Pancreat Surg 2009; 16:292-9.
12. de Santibanes E, Clavien PA. Playing Play-Doh to prevent postoperative liver faliure: the "ALPPS" approach. Ann Surg 2012; 255:415-7. doi: 10.1097/SLA.0b013e318248577d PMID: 22330039
13. Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 2012; 255:405-14. doi: 10.1097/SLA.0b013e31824856f5 PMID: 22330038
14. Tschuor CH, Croome KP, Sergeant G, Cano V, Schadde E, Ardiles V, et al. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion - an extension of the ALPPS approach. Eur J Surg Oncol 2013; 39:1230-5. doi: 10.1016/j.ejso.2013.08.009 PMID: 23994139
15. Schlegel A, Lesurtel M, Melloul E, Limani P, Tschuor C, Graf R, et al. ALPPS: from human to mice highlighting accelerated and novel mechanisms of liver regeneration. Ann Surg 2014; 260:839-847. doi: 10.1097/SLA.0000000000000949 PMID: 25379855
16. Rozga J, Jeppson B, Bengmark S. Portal branch ligation in the rat. Reevaluation of a model. Am J Pathol 1986; 125:300-8. PMID: 3789089
17. Madrahimov M, Dirsch O, Broelsch C, Dahmen U. Marginal hepatectomy in the rat. From anatomy to surgery. Ann Surg 2006; 244:89-98. PMID: 16794393
18. Abraldes JG, Pasarín M, García-Pagán JC. Animal models of portal hypertension. World J Gastroenterol 2006; 12:6577-84. PMID: 17075968
19. Niehues SM, Unger JK, Malinowski M, Neymeyer J, Hamm B, Stockmann M. Liver volume measurement: reason of the difference between in vivo CT-volumetry and intraoperative ex vivo determination and how to cope it. Eur J Med Res 2010; 15:345-50. PMID: 20947471
20. Aller MA, Arias N, Prieto I, Agudo S, Gilsanz C, Lorente L, et al. A half century (1961-2011) of applying microsurgery to experimental liver research. World J Hepatol 2012; 4:199-208. doi: 10.4254/wjh.v4.i7.199 PMID: 22855695
21. Sotiropoulos GC, Kouraklis G. The ALPPS procedure for extended indications in liver surgery: an old finding applied in surgical oncology. Ann Surg 2013; 257:e26. doi: 10.1097/SLA.0b013e3182942e4a PMID: 23629529
22. Kim RD, Kim JS, Watanabe G, Mohuczy D, Behrns KE. Liver regeneration and the atrophy-hypertrophy complex. Semin Intervent Radiol 2008; 25:92-103. doi: 10.1055/s-2008-1076679 PMID: 21326550
23. Schweizer W, Duda P, Tanner S, Balsiger D, Höflin F, Blumgart LH, et al. Experimental atrophy/hypertrophy complex (AHC) of the liver: portal vein, but not bile duct obstruction, is the main driving force for the development of AHC in the rat. J Hepatol 1995; 23:71-8. PMID: 8530812
24. Ferko A, Lesko M, Krajina A, Hulek P, Rösch J, Rabkin J. Intrahepatic portal vein branches after extrahepatic portal vein occlusion. Experimental study. Hepatogastroenterology 2001; 48:475-9. PMID: 11379337
25. Lambotte L, Li B, Leclerq I, Sempoux C, Saliez A, Horsmans Y. The compensatory hyperplasia (liver regeneration) following ligation of a portal branch is initiated before the atrophy of the deprived lobes. J Hepatol 2000; 32:940-5. PMID: 10898314
26. Yao L, Li C, Ge X, Wang H, Xu K, Zhang A, et al. Establishment of a rat model of portal vein ligation combined with in situ splitting. PLOS one 2014; 9:e105511. doi: 10.1371/journal.pone.0105511 PMID: 25144490
27. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 213:286-300. PMID: 17559071
28. Diehl AM, Yin M, Fleckenstein J, Yang SQ, Li HZ, Brenner DA, et al. Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury. Am J Physiol 1994; 267:G552-61. PMID: 7943321
29. Iocca HA, Isom HC. Tumor necrosis factor-alpha acts as a complete mitogen for primary rat hepatocytes. Am J Pathol 2003; 163:465-76. PMID: 12875968
30. Liska V, Treska V, Mirka H, Kobr J, Sykora R, Skalicky T, et al. Tumor necrosis factor-alpha stimulates liver regeneration in porcine model of partial vein ligation. Hepatogastroenterology 2012; 59:496-500. doi: 10.5754/hge10265 PMID: 22353515
31. Boulton R, Woodman A, Calnan D, Selden C, Tam F, Hodgson H. Nonparenchymal cells from regenerating liver generate interleukin1-α and 1-β: a mechanism of negative regulation of hepatocyte proliferation. Hepatology 1997; 26:49-58. PMID: 9214451
32. Ogiso T, Nagaki M, Takai S, Tsukada Y, Mukai T, Kimura K, et al. Granulocyte colony-stimulating factor impairs liver regeneration in mice through the up-regulation of interleukin-1β. J Hepatol 2007; 47:816-25. PMID: 17869372
33. Zhong Z, Tsukada S, Rehman H, Parsons CJ, Theruvath TP, Rippe RA, et al. Inhibition of transforming growth factor-β/Smad signaling improves regeneration of small-for-size rat liver grafts. Liver Transpl 2010; 16:181-90. doi: 10.1002/lt.21966 PMID: 20104486
34. Braun L, Mead JE, Panzica M, Mikumo R, Bell G, Fausto N. Transforming growth factor β mRNA increases during liver regeneration: a possible paracrine mechanism of liver regeneration. PNAS 1988; 85:1539-43. PMID: 3422749
35. Chari RS, Price DT, Sue SR, Meyers WC, Jirtle RL. Down-regulation of transforming growth factor beta receptor type I, II and III during liver regeneration. Am J Surg 1995; 169:126-31. PMID: 7817981
36. 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver. Lab Invest 1990; 63:171-80. PMID: 2381163
37. Thenappan A, Li Y, Kitisin K, Rashid A, Shetty K, Johnson L, et al. Role of transforming growth factor β signaling and expansion of progenitor cells in regenerating liver. Hepatology 2010; 51:1373-82. doi: 10.1002/hep.23449 PMID: 20131405
38. Fausto N. Liver regeneration. J Hepatol 2000; 32 (1 Suppl):19-31. PMID: 10728791
39. Kountouras J, Boura P, Lygidakis NJ. Liver regeneration after hepatectomy. Hepatogastroenterology 2001; 48:556-62. PMID: 11379353
40. Diehl AM, Rai RM. Liver regeneration 3: Regulation of signal transduction during liver regeneration. FASEB J 1996; 10:215-27. PMID: 8641555
41. Boulter L, Govaere O, Bird TG, Radulescu S, Ramachandran P, Pellicoro A, et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med 2012; 18:572-9. doi: 10.1038/nm.2667 PMID: 22388089
42. Bird TG, Boutler L, Cole A, Lorenzini S, Lu WY, Hay T, et al. Manipulation of liver regeneration with macrophages to influence the hepatic progenitor cell niche. Lancet 2013; 381:S23.
43. Mueller L, Grotelueschen R, Meyer J, Vashist YK, Abdulgawad A, Wilms C, et al. Sustained function in atrophying liver tissue after portal branch ligation in the rat. J Surg Res 2003; 114:146-55. PMID: 14559440
44. Schadde E, Ardiles V, Slankamenac K, Tschuor C, Sergeant G, Amacker N, et al. ALPPS offers a better chance of complete resection in patients with primarily unresectableliver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg 2014; 38:1510-9. doi: 10.1007/s00268-014-2513-3 PMID: 24748319
45. Figueras J, Belguiti J. The ALPPS approach: should we sacrifice basic therapeutic rules in the name of innovation?. World J Surg 2014; 38: 1520-1. doi: 10.1007/s00268-014-2540-0 PMID: 24756547
46. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001; 88:165-75. PMID: 11167863
47. Oldhafer KJ, Donati M, Jenner RM, Stang A, Stavrou GA. ALPPS for patients with colorectal liver metastases: effective liver hypertrophy, but early tumor recurrence. World J Surg 2014; 38:1504-9. doi: 10.1007/s00268-013-2401-2 PMID: 24326456